/
  Differentiation of   Differentiation of

  Differentiation of - PowerPoint Presentation

celsa-spraggs
celsa-spraggs . @celsa-spraggs
Follow
405 views
Uploaded On 2017-01-26

  Differentiation of - PPT Presentation

Peri Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma Value of Diffusion Weighted and Perfusion Imaging Dr Nader Zakhari and Dr Thanh Nguyen The Ottawa Hospital ID: 514091

imaging mri findings cortical mri imaging cortical findings diffusion 2013 enhancement contrast increased perfusion left frontal presentation tumor restriction

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "  Differentiation of" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

 Differentiation of Peri-Ictal Pseudoprogression from Tumor Recurrence in a Patient with Treated Glioma: Value of Diffusion Weighted and Perfusion Imaging

Dr Nader Zakhari and Dr Thanh NguyenThe Ottawa Hospital

EE-07 Slide2

DisclosureDr Thanh Binh Nguyen has received an investigator-initiated research grant from Bayer PharmaceuticalSlide3

PurposePeri-ictal pseudoprogression

“PIPG”= Transient MR abnormalities in patients with brain tumor–related seizures

that can incorrectly suggest tumor progression. Slide4

Purpose To present the MR findings of PIPG including diffusion and perfusion imaging.

To differentiate PIPG from true tumor progression and avoid unnecessary interventions.Slide5

Case ReportPresentation: August 2013 36 year-old man

Several simple and complex partial seizures with and without generalization. Slide6

Case ReportHistory: February 2010 3 years earlier was diagnosed with left frontal anaplastic astrocytoma (III/IV)

Treatment (completed in 2010): Surgery Adjuvant radiation (60 Gy in 6 weeks) Concomitant and adjuvant Temozolomide Slide7

Case ReportManagement: August 2013 Admission MRI

Treatment: phenytoin and levetiracetam No recurrence of seizuresSlide8

Imaging findings

Baseline post-operative

MR

(Sept. 2012) before presentation:

Left frontal craniotomy

Postoperative changes

No diffusion restriction

FLAIR

DWISlide9

Imaging findings

T1 post-contrast

CBV

Postoperative changes

No concerning enhancement

No increased

CBV

Baseline post-operative

MR

(Sept. 2012) before presentation:Slide10

Imaging findings

FLAIR

Left frontal cortical swelling and hyperintensity

MRI Aug. 2013 at presentation:Slide11

Imaging findings

Left frontal cortical diffusion restriction

DWI & ADC

MRI Aug. 2013 at presentation:Slide12

Imaging findings

T1 post-

contrast

T1 pre-

contrast

E

nhancement

Left frontal cortical/leptomeningeal enhancement

MRI Aug. 2013 at presentation:Slide13

Imaging findings

Dynamic Susceptibility Contrast Perfusion

Cortical increased

CBV

in the left frontal region

MRI Aug. 2013 at presentation:Slide14

Imaging findings FLAIR

Resolution of swelling and signal abnormalityMRI follow up Oct. 2013:Slide15

Imaging findings DWI and ADC

MRI follow up Oct. 2013:

Resolution of diffusion restrictionSlide16

Imaging findings Enhancement

MRI follow up Oct. 2013:

T1 pre-contrast

T1 post-contrast

Resolution of leptomeningeal/cortical enhancementSlide17

Imaging findings Dynamic Susceptibility Contrast Perfusion

Resolution of increased CBV in the left frontal regionMRI follow up Oct. 2013:Slide18

SummaryPeri-ictal pseudoprogression “PIPG”1

Seizure-associated MR abnormalities in the surgical bed mimicking tumor progression Rare entity ( <1%) Survivors of glioma who have undergone radiotherapy Average 10 years after treatmentSlide19

SummaryPreviously described seizure-associated MRI abnormalities: 2-4

Cortical swellingCortical T2/FLAIR hyperintensityCortical diffusion restriction Cortical and/or leptomeningeal enhancement Increased cerebral blood volume (

rCBV)

Slide20

SummaryMechanism of seizure-associated MRI abnormalities: 2-5 metabolism of seizing neurons

Compensatory blood flow: perfusion metabolism > blood flow:Local tissue hypoxia diffusion restrictionAnaerobic metabolism: lactate & Pco2: vascular dilatation & leakiness disruption of blood brain barrier and

enhancementSlide21

Summary

PIPGTUMOR RECURRENCE

Distribution

Predominantly cortical

Predominantly subcortical

Reversibility

Transient & reversible

Progressive

Diffusion restriction

Cortical

Not limited to the cortex

Not a constant feature

Contrast enhancement

Cortical &/or

focal leptomeningeal

Predominantly subcortical

Leptomeningeal enhancement more common diffuse

Perfusion

Increased

Increased Slide22

ReferencesRheims S, Ricard D, van den Bent M et al. Peri-ictal pseudoprogression in patients with brain tumor. Neuro Oncol. Jul 2011; 13(7): 775–782Rath

JJG, Smits M, Ducray F, van den Bent M. J. Increased rCBV in status epilepticus. J Neurol 2012;259:1746–1748Kim JA, Chung

JI, Yoon PH et al. Transient MR Signal Changes in Patients with Generalized Tonicoclonic Seizure or Status Epilepticus: Periictal

Diffusion-weighted Imaging. AJNR Am J Neuroradiol 2001; 22:1149–1160.

Szabo

K,

Poepel

A,

Pohlmann

-Eden B et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain (2005), 128, 1369–1376

.

Canasa

N,

Breiac

P,

Soares

P et al. The

electroclinical-imagiological

spectrum and long-term outcome of transient

periictal

MRI abnormalities. Epilepsy Research 2010;91:240—252Slide23

THANK YOU